祥生医疗
(688358)
| 流通市值：35.91亿 | | | 总市值：35.91亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 140,596,727.46 | 483,841,135.63 | 401,808,573.78 | 296,398,337.35 |
| 营业收入 | 140,596,727.46 | 483,841,135.63 | 401,808,573.78 | 296,398,337.35 |
| 二、营业总成本 | 88,993,213.8 | 344,438,412.95 | 257,202,310.53 | 175,205,112.22 |
| 营业成本 | 55,368,036.53 | 199,310,909.05 | 160,044,235.47 | 117,853,642.66 |
| 税金及附加 | 1,106,457.03 | 4,024,849.09 | 2,703,219.77 | 1,505,073.62 |
| 销售费用 | 12,432,793.26 | 52,824,392.6 | 37,489,863.21 | 27,751,685.89 |
| 管理费用 | 7,878,988.58 | 34,932,334.24 | 23,621,500.32 | 16,765,373.52 |
| 研发费用 | 19,658,619.98 | 77,071,759.72 | 58,937,647.88 | 37,663,378.98 |
| 财务费用 | -7,451,681.58 | -23,725,831.75 | -25,594,156.12 | -26,334,042.45 |
| 其中:利息费用 | 191,988.6 | 357,351.83 | 223,905.15 | 145,737.4 |
| 其中:利息收入 | 7,004,670.15 | 18,988,335.79 | 12,397,552.42 | 7,219,321.83 |
| 加:公允价值变动收益 | 490,525.97 | 2,927,532.39 | 1,972,407.05 | 2,177,598.33 |
| 加:投资收益 | 1,424,616.2 | 10,613,759.12 | 9,704,644.61 | 6,959,452.05 |
| 资产处置收益 | - | 3,022,739.7 | -68,156.63 | -68,156.63 |
| 资产减值损失(新) | -103,103.6 | -5,534,498.32 | -874,933.78 | -860,602.83 |
| 信用减值损失(新) | -2,017,065.08 | -3,571,489.89 | -6,319,730.26 | -5,309,700.12 |
| 其他收益 | 1,008,802.63 | 15,362,274.62 | 11,691,149.23 | 4,712,564.35 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 52,407,289.78 | 162,223,040.3 | 160,711,643.47 | 128,804,380.28 |
| 加:营业外收入 | 7,000.6 | 406,091.49 | 6,501.33 | 1.33 |
| 减:营业外支出 | 2,937.29 | 435,031.27 | 21,760.57 | 5,557.93 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 52,411,353.09 | 162,194,100.52 | 160,696,384.23 | 128,798,823.68 |
| 减:所得税费用 | 6,871,880.34 | 15,713,413.11 | 19,264,175.67 | 16,833,983.83 |
| 六、净利润 | 45,539,472.75 | 146,480,687.41 | 141,432,208.56 | 111,964,839.85 |
| 持续经营净利润 | 45,539,472.75 | 146,480,687.41 | 141,432,208.56 | 111,964,839.85 |
| 归属于母公司股东的净利润 | 45,539,472.75 | 146,480,687.41 | 141,432,208.56 | 111,964,839.85 |
| (一)基本每股收益 | 0.41 | 1.33 | 1.26 | 1 |
| (二)稀释每股收益 | 0.41 | 1.33 | 1.26 | 1 |
| 八、其他综合收益 | 5,596.95 | 1,229.69 | 170,205.67 | 16,236.48 |
| 归属于母公司股东的其他综合收益 | 5,596.95 | 1,229.69 | 170,205.67 | 16,236.48 |
| 九、综合收益总额 | 45,545,069.7 | 146,481,917.1 | 141,602,414.23 | 111,981,076.33 |
| 归属于母公司股东的综合收益总额 | 45,545,069.7 | 146,481,917.1 | 141,602,414.23 | 111,981,076.33 |
| 公告日期 | 2024-04-19 | 2024-04-19 | 2023-10-27 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |